Mucoadhesion and the gastrointestinal tract

Area of Science:

• Pharmaceutical Sciences
• Gastroenterology
• Drug Delivery Systems

Background:

• Mucoadhesion offers potential to standardize drug residence times in the gastrointestinal tract, improving therapeutic efficacy.
• Current mucoadhesive strategies primarily target the stomach and small intestine with limited human success.
• The lower gastrointestinal tract, particularly the colon, presents unique physiological advantages for mucoadhesion.

Purpose of the Study:

• To review the principles and physiological considerations of mucoadhesion in the gastrointestinal tract.
• To examine existing mucoadhesive drug delivery approaches.
• To highlight the largely unexplored potential of the lower gut for mucoadhesive applications.

Main Methods:

• Literature review of mucoadhesion principles and gastrointestinal physiology.
• Analysis of in vitro and in vivo studies on mucoadhesive drug delivery.
• Evaluation of factors influencing mucoadhesion in the lower gut.

Main Results:

• Mucoadhesion can enhance drug absorption and topical therapy through intimate mucosal contact.
• While promising in vitro, mucoadhesive approaches have not yet translated to human success in the upper GI tract.
• The colon's lower motility, reduced mucus turnover, and thicker mucus layer suggest significant potential for successful mucoadhesion.

Conclusions:

• The lower gastrointestinal tract, especially the colon, represents a promising, yet underutilized, site for mucoadhesive drug delivery.
• Further research into colonic mucoadhesion could overcome limitations seen in upper GI applications.
• Rectal administration studies indicate positive in vivo outcomes, supporting lower gut mucoadhesion strategies.